Sunday, 28 May 2023


Elevation Oncology Climbs 57% By

D.C. man gets record-tying 63-month sentence for role in U.S. Capitol riot

Elevation Oncology (ELEV) Climbs 57%

(Updated – May 26, 2023 10:50 AM EDT)

Elevation Oncology (ELEV) Climbs 57%

  • Hedge fund Point72 recently disclosed an 8.7% stake in the company
  • Today’s gain appear related to early-stage data for its treatment of gastric cancer at ASCO. The abstract was for “First-in-human dose escalation and expansion study of SYSA1801, an antibody-drug conjugate targeting claudin 18.2 in patients with resistant/refractory solid tumors.”

Click Here to Read the Full Original Article at All News…